Jiyang Yu1, Jose Silva2, Andrea Califano1. 1. Department of Biomedical Informatics, Department of Systems Biology, Center for Computational Biology and Bioinformatics, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA and. 2. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Abstract
MOTIVATION: Functional genomics (FG) screens, using RNAi or CRISPR technology, have become a standard tool for systematic, genome-wide loss-of-function studies for therapeutic target discovery. As in many large-scale assays, however, off-target effects, variable reagents' potency and experimental noise must be accounted for appropriately control for false positives. Indeed, rigorous statistical analysis of high-throughput FG screening data remains challenging, particularly when integrative analyses are used to combine multiple sh/sgRNAs targeting the same gene in the library. METHOD: We use large RNAi and CRISPR repositories that are publicly available to evaluate a novel meta-analysis approach for FG screens via Bayesian hierarchical modeling, Screening Bayesian Evaluation and Analysis Method (ScreenBEAM). RESULTS: Results from our analysis show that the proposed strategy, which seamlessly combines all available data, robustly outperforms classical algorithms developed for microarray data sets as well as recent approaches designed for next generation sequencing technologies. Remarkably, the ScreenBEAM algorithm works well even when the quality of FG screens is relatively low, which accounts for about 80-95% of the public datasets. AVAILABILITY AND IMPLEMENTATION: R package and source code are available at: https://github.com/jyyu/ScreenBEAM. CONTACT: ac2248@columbia.edu, jose.silva@mssm.edu, yujiyang@gmail.com SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: Functional genomics (FG) screens, using RNAi or CRISPR technology, have become a standard tool for systematic, genome-wide loss-of-function studies for therapeutic target discovery. As in many large-scale assays, however, off-target effects, variable reagents' potency and experimental noise must be accounted for appropriately control for false positives. Indeed, rigorous statistical analysis of high-throughput FG screening data remains challenging, particularly when integrative analyses are used to combine multiple sh/sgRNAs targeting the same gene in the library. METHOD: We use large RNAi and CRISPR repositories that are publicly available to evaluate a novel meta-analysis approach for FG screens via Bayesian hierarchical modeling, Screening Bayesian Evaluation and Analysis Method (ScreenBEAM). RESULTS: Results from our analysis show that the proposed strategy, which seamlessly combines all available data, robustly outperforms classical algorithms developed for microarray data sets as well as recent approaches designed for next generation sequencing technologies. Remarkably, the ScreenBEAM algorithm works well even when the quality of FG screens is relatively low, which accounts for about 80-95% of the public datasets. AVAILABILITY AND IMPLEMENTATION: R package and source code are available at: https://github.com/jyyu/ScreenBEAM. CONTACT: ac2248@columbia.edu, jose.silva@mssm.edu, yujiyang@gmail.com SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Jose M Silva; Hana Mizuno; Amy Brady; Robert Lucito; Gregory J Hannon Journal: Proc Natl Acad Sci U S A Date: 2004-04-14 Impact factor: 11.205
Authors: Hiu Wing Cheung; Glenn S Cowley; Barbara A Weir; Jesse S Boehm; Scott Rusin; Justine A Scott; Alexandra East; Levi D Ali; Patrick H Lizotte; Terence C Wong; Guozhi Jiang; Jessica Hsiao; Craig H Mermel; Gad Getz; Jordi Barretina; Shuba Gopal; Pablo Tamayo; Joshua Gould; Aviad Tsherniak; Nicolas Stransky; Biao Luo; Yin Ren; Ronny Drapkin; Sangeeta N Bhatia; Jill P Mesirov; Levi A Garraway; Matthew Meyerson; Eric S Lander; David E Root; William C Hahn Journal: Proc Natl Acad Sci U S A Date: 2011-07-11 Impact factor: 11.205
Authors: Tao Deng; Jeff C Liu; Philip E D Chung; David Uehling; Ahmed Aman; Babu Joseph; Troy Ketela; Zhe Jiang; Nathan F Schachter; Robert Rottapel; Sean E Egan; Rima Al-Awar; Jason Moffat; Eldad Zacksenhaus Journal: Cancer Res Date: 2014-01-31 Impact factor: 12.701
Authors: David Sims; Ana M Mendes-Pereira; Jessica Frankum; Darren Burgess; Maria-Antonietta Cerone; Cristina Lombardelli; Costas Mitsopoulos; Jarle Hakas; Nirupa Murugaesu; Clare M Isacke; Kerry Fenwick; Ioannis Assiotis; Iwanka Kozarewa; Marketa Zvelebil; Alan Ashworth; Christopher J Lord Journal: Genome Biol Date: 2011-10-21 Impact factor: 13.583
Authors: Wei Li; Han Xu; Tengfei Xiao; Le Cong; Michael I Love; Feng Zhang; Rafael A Irizarry; Jun S Liu; Myles Brown; X Shirley Liu Journal: Genome Biol Date: 2014 Impact factor: 13.583
Authors: Abhishek Bharadwaj Sharma; Hélène Erasimus; Lia Pinto; Marie-Christine Caron; Diyavarshini Gopaul; Thibaut Peterlini; Katrin Neumann; Petr V Nazarov; Sabrina Fritah; Barbara Klink; Christel C Herold-Mende; Simone P Niclou; Philippe Pasero; Patrick Calsou; Jean-Yves Masson; Sébastien Britton; Eric Van Dyck Journal: Nucleic Acids Res Date: 2021-09-27 Impact factor: 16.971
Authors: James M McFarland; Zandra V Ho; Guillaume Kugener; Joshua M Dempster; Phillip G Montgomery; Jordan G Bryan; John M Krill-Burger; Thomas M Green; Francisca Vazquez; Jesse S Boehm; Todd R Golub; William C Hahn; David E Root; Aviad Tsherniak Journal: Nat Commun Date: 2018-11-02 Impact factor: 14.919